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While a decrease of wild felid population has led to disruption of conservation 
programme, recent studies have shown the importance of immune regulation for 
determining health outcomes and co-infection. Immunoglobulin G is important for 
detecting and evaluating responses to infectious diseases and vaccination. But, there 
is limited information on felid immunoglobulins and their role for functional immunity. 
This study aimed at isolating and characterizing lion’s immunoglobulin G.  Lions’ sera 
(n = 68) were processed using the MagReSyn® magnetic beads and the final protein 
concentration was determined using the Xpose™ Trinean Spectrophotometer. The 
cross-reactivity of goat anti-cat immunoglobulin with sera of lions and other species 
was analysed using ELISA.  High cross-reactivity was observed in lions ranging from 
87.7 to 100%, and low reactivity with rhino (22.4%) followed by chicken (0.01%).  The 
protein concentration from purified sera yielded 39.09 mg/ml.  Molecular weight of lion 
IgG 150-160 kDa was detected with both chains at 54-56 kDa and 24-26 kDa on SDS-
PAGE.  These results indicate a potential aid in developing serological tools to monitor 
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Chapter 1: Literature Review 
 
Increasing anthropogenic pressure on economically and ecologically important 
domestic and wildlife species, as well as the recognition of certain species as a viable 
model for both human and animal diseases, has led to the expansion of animal health 
research worldwide (Broughton, 2017, Hassell et al., 2017). As these changes 
occurred, domestic species, including cats (Felis catus) have been used to study 
immune mechanisms for disease susceptibility, because of their social importance to 
humans as members of the family, as well as the analogous nature of their immune 
system to that of humans (Combes, 1996, Pastoret et al., 1998). However, while a 
large body of scientific evidence now exists to characterize most branches of the 
immune system in domestic cats, less is known about immune profiles of free-ranging 
felids, including lions (Panthera leo) due to the general inaccessibility of samples from 
these species.  
 
Populations of wild felids are vulnerable and decreasing in their natural habitat. This 
is due to biosphere changes, prey depletion, human-lion conflict and exposure to 
infectious diseases of domestic animals, humans, and other wildlife species, which act 
as continual reservoirs of infection (Kelly et al., 1993, Thalwitzer et al., 2010, Brown, 
2011, Packer et al., 2011, Riggio et al., 2013, Henschel et al., 2014, McDermid et al., 
2017). In view of the above mentioned threats, understanding the immune 
mechanisms that may underlie disease susceptibility and provide protection against 
large scale population crashes in the face of disease outbreaks has become 
paramount (Dalerum et al., 2008, Ferreira et al., 2013). Hyenas like other predators 
that hunt and scavenge namely black backed jackal, have shown the ability to survive 
infectious diseases such as anthrax, rabies and other infectious diseases of carnivores 
(Bellan et al., 2012, Flies et al., 2012). 
The Kruger National park (KNP) is one of the largest game reserves in Africa and 
covers an area of 19 485 km² (Joubert, 1986). This area is home to a diverse 
population of wild animals, which include small felids such as caracal (Caracal 
caracal), servals (Leptailurus serval) and African wild cats (Felis lybica) and large 
felids such as cheetahs (Acinonyx jubatus), leopards (Panthera pardus) and African 
lions (Panthera leo) (Fairall, 1968).  
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Cheetah and leopard populations in the park are decreasing due to their susceptibility 
to infectious diseases such as tuberculosis (Thalwitzer et al., 2010, Viljoen et al., 
2015).  
Lions have a relatively large population in the park compared to other felids, bolstered 
mostly by a higher rate of survival due to their affiliation with social groups (prides) 
consisting of more than one male, which provides protection for young and territory, 
as well as increased efficiency with regards to prey handling (Dalerum et al., 2008, 
Viljoen et al., 2015).  In addition, they feed on a variety of prey species and have low 
water requirements due to their ability to meet hydration needs through consumption 
of water in prey tissues, conferring resistance against droughts in the face of large die-
offs of other species (Eloff, 1973, Funston et al., 1998).  Despite this resilience, recent 
years have seen a decrease in lion populations due to increasing pressure from 
poachers along park boundaries, as well as local epizootics caused by diseases 
transmitted by sympatric species (Ferreira et al., 2013). 
1.1 Infectious diseases of lions  
Past studies investigating bacterial, viral, protozoal and other parasitic diseases in 
lions and other felid populations have shown KNP to have a high disease prevalence 
throughout various regions of the park (Antunes et al., 2008, Ferreira and Funston, 
2010, Maas et al., 2010, Maas et al., 2012b, Broughton, 2017).  Furthermore, recent 
studies have shown the importance of immune regulation for determining health 
outcomes and co-infection dynamics as regulated by viral and parasitic coinfections 
of known importance (Broughton, 2017).  Despite these findings, there is limited 
information on felid immunoglobulins and their role for functional immunity in these 
threatened species. 
1.1.1 Bacterial diseases of lions 
Some bacteria species in the genera of Bartonella, Mycobacterium and Mycoplasma 
have been reported to cause disease in domestic cats and free-ranging lions (Viljoen 
et al., 2015, Molia et al., 2016). 
Bartonellaceae are aerobic, gram-negative bacteria transmitted by vectors such as 
lice, flea, sandflies and ticks (Noguchi, 1926, Jacomo et al., 2002, Billeter et al., 2008, 
Chomel et al., 2009). The bacteria infect erythrocytes, endothelial cells and 
macrophages which leads to disease (Billeter et al., 2008). Bartonellae species such 
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as Bartonella clarridgeiae and Bartonella koehlerae have been isolated from animals 
and humans, and felids are found to be a source of infection (Molia et al., 2004).  Cat 
scratch disease is the most common disease in domestic cats and other felids, 
including lions caused by Bartonella henselae (B. henselae) (Pretorius et al., 2004, 
Chomel et al., 2006, Molia et al., 2016). Clinical symptoms of Bartonella species 
include fever (in humans), swollen lymph nodes, endocarditis and neuroretinitis 
(Rotstein et al., 2000, Molia et al., 2004, Pretorius et al., 2004).  In the study conducted 
by Molia et al. (2004), B. henselae was identified in both lions and cheetah by 
polymerase chain reaction (PCR) using cultured colonies from whole blood pellets.  
Bartonella henselae was also isolated by culture and identified using PCR and ELISA 
in lions from three ranches in the Free State Province (Pretorius et al., 2004).  
Mycobacterium bovis is a gram-positive rod-shaped bacterium, non-motile, aerobic, 
does not form any spores and is acid fast staining (Quinn et al., 1994).  M. bovis 
organisms are slow growers and culture results can take up to 16 weeks to be 
confirmed as negative (Wadhwa and Mahajan, 2006).  Mycobacterium bovis, a 
member of the Mycobacterium tuberculosis complex (MTBC), which also includes M. 
tuberculosis, M. caprae, M. microti, M. africanum, M. canettii , M. pinnipedii, M. orygis, 
M. bovis, bacilli Calmette-Guérin (BCG), M. mungi, M. suricattae and the dassie 
bacillus (Bass et al., 2013).  Mycobacterium bovis causes tuberculosis in domestic and 
wild animals (Michel et al., 2010, Musoke et al., 2015).  
There have been reports on African wildlife species infected with M. bovis since 1929. 
These include primates and non-primates (Keet et al., 1996, De Vos et al., 2001, 
Cleaveland et al., 2005, Michel et al., 2006, Trinkel et al., 2011, Viljoen et al., 2015). 
Tuberculosis was first detected in the 90’s from African buffalo in the KNP and since 
then has spread to other parts of the park to a diverse number of wildlife species 
including lions (Michel et al., 2006, Viljoen et al., 2015).  The route of exposure to other 
species including lions has been studied in detail and Miller et al. (2015) confirmed 
infection through the respiratory system using tracheobronchial lavage samples from 
the KNP lions.  
M bovis in lions was first reported in the KNP in 1996 (Keet et al., 1996, Sylvester et 
al., 2017). Lions can contract an M. bovis infection by consuming infected prey, such 
as buffalo, the reservoir host of the disease in South Africa (Keet et al., 1996, Viljoen 
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et al., 2015).  The main clinical symptom caused by M bovis in lions is emaciation and 
pulmonary and bone lesions post-mortem (Keet et al., 1996, Miller et al., 2019). The 
diagnosis of M bovis infection in lions has been documented and included post mortem 
examination, isolation on culture, microscopic examination and histopathology 
examination, immunological assays (ELISA, interferon-gamma assay and tuberculin 
skin test) and molecular tests (PCR) (Maas, 2011, Viljoen et al., 2015, Miller et al., 
2019, Viljoen et al., 2019).  
 
Bacillus anthracis is an aerobic or facultative anaerobic gram-positive bacterium that 
forms spores (Russell et al., 2008, Koehler, 2009). The bacteria is extracellular with 
an intracellular presence during pulmonary anthrax (Russell et al., 2008). The 
ubiquitous bacterium can survive for a long time in dried culture and can remain viable 
in soil for many years (Smith et al., 2000, Lembo et al., 2011, Steenkamp et al., 2018). 
Anthrax is a contagious disease of domestic, wild mammals and humans (Hugh-Jones 
and De Vos, 2002, Hampson et al., 2011). Anthrax in lions in KNP has been diagnosed 
and infection is through opening of carcass by scavengers, feeding from infected prey 
and drinking from infected water holes (Hugh-Jones and De Vos, 2002). The swelling 
of the head is one of the clinical signs observed in the early stages of infection in lions. 
Lions develop a strong (antibody) immunity to anthrax after the first few exposures. 
Histopathology, serologic testing (ELISA), bacterial culture and molecular techniques 
are used for identification of the bacteria  (WHO, 2008, Range, 2011). 
 
Clostridium is a gram-positive spore-forming anaerobic bacteria causing diseases in 
humans and animals (Rorbye et al., 2000, Greco et al., 2005). The natural habitat of 
Clostridium species are the soil, water and gastrointestinal tract of both animals and 
humans (Haagsma, 1991, Rorbye et al., 2000, De la Fe et al., 2006). C.tetani, C. 
perfrigens, C. botulinum, C. septicum and C. bifermentans are Clostridium species 
isolated from humans and animals (De la Fe et al., 2006). De la Fe et al. (2006) 
reported the first case of C. sordellii in lions. The clinical symptoms observed 
include ataxia, paralysis and exhaustion (Greenwood, 1985, De la Fe et al., 2006). 
Cases of C. perfringens and C. sordellii were also identified and isolated in other 
felines (Greco et al., 2005, Zhang et al., 2012). Polymerase chain reaction test, 
bacteriological culture, gram-stain technique and indirect fluorescent antibody (IFA) 
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test are often used to identify the bacteria (Greco et al., 2005, De la Fe et al., 2006, 
Zhang et al., 2012). 
 
1.1.2 Viral diseases of lions 
Diseases of wild carnivores have been studied worldwide with outcomes of most 
carnivores surviving other diseases (Flies et al., 2012).  Wild felids are susceptible to 
many viruses (canine distemper virus, feline immunodeficiency virus, feline leukaemia 
virus, feline panleukopenia virus) affecting domestic cats and humans (Spencer, 1991, 
Endo et al., 2004, Dybas, 2009).  
Feline panleukopenia virus (FPLV) belongs in the Parvoviridae family.  FPLV is a 
single-stranded DNA virus of about 18 to 26 nm in diameter (Povey and Davis, 1977, 
Agbandje et al., 1993).  Feline panleukopenia has been reported in lions and other 
species with the first report diagnosed from a leopard (Johnson, 1964, Povey and 
Davis, 1977, Spencer, 1991, Endo et al., 2004). Spencer (1991) then confirmed the 
occurrence of FPLV in free-ranging lions in the KNP. 
Canine distemper virus (CDV) is a member in the family of Paramyxoviridae, genus 
morbillivirus. This enveloped single-stranded, negative sense RNA virus has viral 
attachment spikes (Bellini et al., 1986, De Vries et al., 2015, Rendon-Marin et al., 
2019).  As an infectious disease, canine distemper is recognized worldwide and has 
been reported in carnivores (Deem et al., 2000, Loots et al., 2018).  Canine distemper 
disease was diagnosed in lions from the Serengeti National Park in Tanzania in the 
90’s using histopathology and serology test (Roelke-Parker et al., 1996).  This 
outbreak in lions and other large felids resulted in the death and decline in the lion 
population (Roelke-Parker et al., 1996, Endo et al., 2004).  In addition, large felines 
that are tested serologically for FPLV and CDV also have antibodies against feline 
immunodeficiency virus (FIV).  The felids have extensive exposure to most of the 
common feline and canine viruses (Roelke-Parker et al., 1996, Endo et al., 2004, 
Driciru et al., 2006). 
Gaskell et al. (2007) describe feline herpes virus (FHV) as an alpha herpesvirus of 
cats closely related to canine herpesvirus-1 and porcine herpesvirus-1.  Hofmann-
Lehmann et al. 1996 confirmed the prevalence of FHV in lions using Enzyme-linked 
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immunosorbent assay (ELISA).  Feline herpes virus and other viruses (FIV, FCV, 
feline parvovirus, feline coronavirus and CDV) of felids were also diagnosed in lions 
of Serengeti and Tanzania in 1999.  Feline leukaemia virus was not detected from the 
lions in the studies conducted using serological tests (Hofmann-Lehmann et al., 1996, 
Packer et al., 1999). 
Feline calicivirus (FCV) is a small single-stranded, positive-sense RNA virus of cats 
and is widespread in the feline population (Maeda et al., 1998, Radford et al., 2007, 
Thiry et al., 2009, Henzel et al., 2015).  The pathogen has been reported in African 
lions (Martella et al., 2007).  Nasal, oral or conjunctival are routes of infection (Radford 
et al., 2007).  Together with FHV, the pathogen is identified  from cellular culture, IFA, 
serology and PCR (Henzel et al., 2015).  The immune response against FCV infection 
depends on host factor and feline immune status (Radford et al., 2007, Henzel et al., 
2015). 
Feline immunodeficiency virus is a T-lymphotropic pathogenic lentivirus of domestic 
cats and has been detected in several non-domestic feline species (Callanan et al., 
1992, VandeWoude et al., 1997, Roelke et al., 2006). The FIV causes 
immunosuppression in domestic cats (Brown et al., 1994, Roelke et al., 2009).  It was 
discovered by (Pedersen et al., 1987) as the etiologic agent of an immunodeficiency 
syndrome in cats (Roelke et al., 2006).  Studies have shown that FIV can infect lions 
(Brown et al., 1993, Brown et al., 1994, Poli et al., 1995, Hofmann-Lehmann et al., 
1996, Troyer et al., 2005, Brennan et al., 2006, Roelke et al., 2006, Maas et al., 
2012a).  Free-ranging lions carry the FIV (lion) (FIV-Ple), which is the chronic species-
specific strain of FIV (Troyer et al., 2005, Roelke et al., 2009).  In most studies, 
serological tests (ELISA, IFA, Western Blot techniques) are conducted to detect the 
antibodies to FIV (Hofmann-Lehmann et al., 1996).  Molecular cloning and complete 
nucleotide sequencing are also used (Olmsted et al., 1989, Poli et al., 1995, McEwan 
et al., 2008).  Immune (CD4+ T-lymphocytes) depletion is recorded as one of the 
pathological conditions related to lentivirus infections (Roelke et al., 2009).   
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which causes 
corona-virus-disease (CoViD-19) in humans was also detected in some animals 
(Newman et al., 2020, Sit et al., 2020).  It is a single-stranded positive sense RNA 
virus with spike proteins (Newman et al., 2020, Sit et al., 2020) and appears spherical 
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in shape (Tufan et al., 2020).  The Wildlife Conservation Society’s Bronx Zoo in New 
York reported the first natural infection case of SARS-CoV-2 cases in lions and tigers. 
Zoo keepers, who tested positive for the infection, have transmitted the virus to the 
animals since they had close contact with the animals (McAloose et al., 2020).  African 
lions are also reported to be infected with feline coronavirus (FCoV), a contagious 
pathogen of domestic and non-domestic Felidae (Kennedy et al., 2002, Kennedy et 
al., 2003, Stephenson et al., 2013). The two forms of FCoV include feline enteric 
coronavirus (FECV) which causes intestinal infection in young felids (Pedersen et al., 
1981) and feline infectious peritonitis virus (FIPV) causing feline infectious peritonitis 
(FIP), a fatal immune-mediated vasculitis of felids (Poland et al., 1996, Kennedy et al., 
2003, Stephenson et al., 2013).  Clinical symptoms associated with FCov infection are 
fever, weight loss and chronic diarrhoea (Kennedy et al., 2002, Stephenson et al., 
2013).  PCR and IFA are mostly used to identify the virus (Kennedy et al., 2002, 
Kennedy et al., 2003, Stephenson et al., 2013). 
Papillomaviruses (PVs) are small, non-enveloped, double-stranded DNA viruses. 
They are highly species specific pathogens of felids (Sundberg et al., 2000, Rector et 
al., 2007).  All PVs belong to the Lambda papillomavirus genus (Rector et al., 2007). 
The infected species develop localised proliferative lesions caused by injection of the 
infectious virions through the skin surface.  Papillomaviruses are also thought to cause 
feline sarcoids, a cutaneous fibropapilloma (Carney et al., 1990, Hanna and Dunn, 
2003).  This virus was identified in Persian cats using electron microscopy technique 
and immunohistochemical analysis (Carney et al., 1990). In 2000, (Sundberg et al.) 
reported feline papillomavirus in six cat species (Felis domesticus, Felis concolor, Felis 
rufus, Panthera leo, Panthera uncia and Neofelis nebulosa) using histological and 
immunohistochemistry techniques. The cat lesions had similar clinical appearance to 
those in humans. 
 
1.1.3 Protozoal diseases of lions  
Protozoan parasites, such as Leishmania, Giardia, Cryptosporidium and Toxoplasma 
parasites are found in felids. These parasites can be transmitted via consumption of 
either undercooked food or contaminated water and arthropod vectors (Bjork et al., 
2000, Otranto et al., 2015). 
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Toxoplasma gondii is a coccidian parasite of felids and humans and is divided into 
three stages, the tachyzoites, bradyzoites and sporozoites.  In the tachyzoites stage, 
the parasites enter the host cell and multiply rapidly.  Bradyzoites include the slow 
multiplication of cysts within the tissue and sporozoites stage occur in the oocysts and 
sporulation occurs (Dubey et al., 1998, Tenter et al., 2000). Felids are the only known 
definitive hosts of Toxoplasma gondii shedding oocysts in the environment and 
providing the infection to other warm-blooded animal species (Lappin et al., 1991, 
Yang et al., 2017, Ferra et al., 2020).  Riemann et al. (1975) reported the first case of 
Toxoplasma gondii in a lion from Serengeti National Park, Tanzania.  The lion was 
seropositive to Toxoplasma gondii using indirect haemagglutination assay (IHA) 
(Penzhorn et al., 2002).  Toxoplasma gondii and Neospora caninum are closely related 
parasites of felines and canids (Kamga-Waladjo, 2009, Pedrosa, 2018). The two 
parasites were investigated in lions using serum samples for ELISA to examine 
antibodies against Toxoplasma gondii and Neospora caninum, respectively.  The 
serological results indicated more exposure to Neospora caninum than Toxoplasma 
gondii. Agglutination test and PCR are also used to detect the presence of 
Toxoplasma gondii (Kamga-Waladjo, 2009).  Lions, like other felids are the only 
definitive hosts of Toxoplasma gondii. The oocysts shed in the faeces provide an 
infection in various warm-blooded animal species (Yang et al., 2017).  The infection of 
protozoan parasite remains prevalent in lions and other wild felids (Ferreira et al., 
2019, Seltmann et al., 2020). 
Cryptosporidium and Giardia are parasites that can infect domestic animals, wild 
animals and humans causing diarrhoea and other enteric disorders. The transmission 
of these parasites is by pollution from faecal material of both humans and animals. 
Molecular tests have shown that both strains of Cryptosporidium and Giardia are found 
in captive and free-ranging wildlife animals (Appelbee et al., 2005). 
Babesia are tick-transmitted hemoprotozoans that infect mammals and birds 
(Schnittger et al., 2012). Penzhorn et al. (2001) reported the first characterization of 
felid babesia parasite in lions using PCR.  Various wild carnivores have been reported 
to have babesia.  Babesia species have also been described from different animal 
species namely dogs, mongoose, hyena, racoons, rhinoceros, elephants, Bovidae, 
Cervidae and felids.  All the lions in the KNP tested during the study were found to be 
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infected with Babesia leo (Penzhorn, 2006).  Babesia was also reported in the lions of 
the Serengeti in Tanzania as a threat to the future of lions (Dybas, 2009).    
Other vector borne diseases are transmitted by Ixodid ticks, ectoparasites also found 
in wild felids.  Amblyoma sp, Hyalomma sp. and Rhipicephalus sp. were identified in 
wild felids, including lions.   In the study by Horak et al. (2010) cats and wild felids 
were concluded as good hosts for Hyalomma elliptica (Horak et al., 2010). 
1.1.4 Other parasites of lions  
Other parasites in African lions have been reported across Africa (Bjork et al., 2000, 
Hüttner et al., 2008).  The table below summarises the studies on micro and macro 
parasites of African lions. Bjork et al. (2000) identified 19 different parasites from the 
free-ranging African lions in the Serengeti national park and Ngorongoro conservation 
area.  Freshly defecated faecal samples were collected. The study indicated that the 
structures of cestode and trematode studied could have originated from other animal 















Table 1: Summary of parasites identified in African lions  
Parasite  Place  Samples  Tests conducted  
Cestoda       
Spirometra sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Echinococcus felidis Uganda  Faeces 
Egg counts and 
nuclear DNA 
sequencing  
Taenia sp. Tanzania Faeces Egg counts  
Anoplocephalidae 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Trematoda       
Trichuris sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Nematoda       






Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Trichinella sp. 
Greater Kruger National Park, South 
Africa  various Various 
Capillaria sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Habronema sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Others       
Acanthocephala 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Demodex sp. 
 





Egg counts  
 
Eimeria sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  
Isospora sp. 
Serengeti and Ngorongoro Crater, 
Tanzania Faeces Egg counts  




1.2 General immunology 
Recent studies have shown the importance of immune regulation for determining 
health outcomes and coinfection dynamics as regulated by viral and parasitic 
coinfections of known importance (Broughton, 2017).  Despite these findings, there is 
limited information on felid immunoglobulins and their role for functional immunity in 
these threatened species. 
Delves and Roitt (2000) describe the immune system as a collection of cells and 
molecules that help protect against infection (Parham, 2014).  It has two major arms, 
innate immunity which is present from birth and adaptive immunity which develops 
from birth and continues to do so as the individual is exposed to different antigens 
during its lifetime (Roitt et al., 1989, Beutler, 2004, Turvey and Broide, 2010).  Microbial 
infections are recognised by the innate immune system to produce immediate defence 
and to also generate a long-lasting adaptive immunity  (Iwasaki and Medzhitov, 2015). 
 
1.2.1 Innate immunity 
Innate immunity represents the principal defence machinery in vertebrates.  It 
responds in minutes and hours of an antigen appearance to the body. It is non-specific 
and does not exhibit memory.  It is the first line of defence that fights any foreign 
invaders and is found in organisms such as insects and plants (Roitt et al., 1989, 
Tizard Ian, 1996, Bonilla and Oettgen, 2010). 
1.2.2 Adaptive immunity 
Adaptive immunity also known as specific immunity is a lymphocyte dependent 
immune system with various antigen receptors and exhibits immunologic memory. 
Adaptive immunity consists of cell-mediated immunity (CMI) and humoral immunity 
(HI). Cell-mediated immunity is mediated by T-cells and targets intracellular-
pathogens.  In CMI, the effector phase is initiated by T-cells recognizing the peptide-
Major Histocompatibility Complex (MHC) antigens on activated antigen presenting 
cells.  These cells play a role in eliminating microbes and other sources of antigen by, 
stimulating inflammation through secretion of cytokines and killing pathogen infected 
cells and phagocytosed and extracellular microbes. There are two response types of 
CMI, the CD4+ helper T-cell which respond to microbes phagocytosed by phagocytes 
and the CD8+ cytolytic T-cell which responds to microbes that infect and replicate 
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intracellularly in various cell types (Roitt et al., 1989, Bonilla and Oettgen, 2010, Tubo 
and Jenkins, 2014).  
Humoral immunity is mediated by antibodies and targets extra-cellular pathogens. 
During HI, antibodies are secreted by activated B-lymphocytes (plasma cells) and bind 
to an antigen. The antigen will then be neutralized, and phagocytosis will take place. 
Adaptive or active immunity can be stimulated by an infectious agent or by 
immunization/ vaccination. This is in contrast to passive immunity conferred by 
antibodies present in body fluids, which can be transferred to another individual to 
provide protection (Roitt et al., 1989, Bonilla and Oettgen, 2010). 
1.2.3 Passive and active immunity 
Immunity is the state of resistance to an infection and has both specific and non-
specific mechanisms.  The state of resistance to an infection can be acquired by 
passive or active immunity (Tizard Ian, 1996).  
1.2.3.1 Passive immunity 
During passive immunization, antibodies are transferred from a resistant animal to a 
susceptible animal for immediate protection against an antigen such as, antibody 
transfer naturally from mother to baby via placenta and from breast milk/ colostrum or 
artificially from an immune donor. It can also be induced artificially where antibodies 
produced in a donor animal by active immunisation are administered to susceptible 
animals for immediate immune protection  (Roitt et al., 1989, Tizard Ian, 1996). 
1.2.3.2 Active immunity 
Active immunity is induced after the administration of antigen to an animal to provide 
a long lasting protective immune response.  There are two types of active immunity, 
natural and artificial immunity.  Natural immunity is activated after exposure to the 
antigen and happens naturally. Artificial immunity is induced after a vaccine is 
administered and the animal develops its own antibodies.  Vaccinations are made of 
specific antigens; they are administered to protect animals against infectious diseases 
and generate an active immune response.  Exposure of disease results in cells of the 
animal’s immune system interacting with the organism, therefore antigen producing 
cells must be stimulated followed by stimulation of B-cells and T-cells to produce large 




Figure 1: A brief overview of the immune system and functions (Roitt et al., 1989, 
Tizard Ian, 1996, Tizard, 2013). 
1.3 Immunoglobulins  
The immunoglobulins (Igs), also called antibodies, are a group of glycoproteins found 
in serum, plasma and tissue fluids of all mammals.  The major proteins found in blood 
are fibrinogen (only in plasma), globulins and albumins.  The maturity of the B-cells 
takes place in the bone marrow and then develop into lymphocytes responsible for 
antibody production and plasma cells in response to an antigen. B-cells express 
proteins (immunoglobulins) on their cell surfaces. The B-cell receptors (BCRs) are 
formed by immunoglobulins and secrete the same immunoglobulins circulating as 
antibodies. These immunoglobulins bind to a specific antigen (Gally, 1973, Nisonoff, 
1983, Tizard Ian, 1996, Frank, 2002, Bhattacharya, 2008).  
The basic structure of an Ig consists of disulphide bonds and four polypeptide chains, 
the two light chains (L) and the two heavy chains (H) containing variable regions (VH 
or VL) at the N terminal.  The C terminal is part of the constant region.  The light chains 
have a molecular mass of 25 000 Daltons and the heavy chains have 70 000 Daltons.  
The light chain and heavy chain are linked by a disulphide bond to form an H-L bond.  
The two H-L bonds are then connected by another disulphide bond to form a full 
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structure of immunoglobulin (Neoh et al., 1973, Huse et al., 2002, Bhattacharya, 2008, 
Schroeder Jr and Cavacini, 2010). 
The IgG molecule as shown in figure 2 consists of two identical fragments, antigen 
binding (Fab) region;  the antigen binding site and one Fc (fragment, crystallisable) 
region both connected by a hinge region which allows the distance between the two 
antigen-binding sites to vary and is found only in IgG, IgA and IgD.  IgM and IgE lack 
the hinge region, instead each have an additional constant domain.  Each of the Fab 
regions consists of two domains, the VH-VL and CH1-C1 whereas the Fc region has two 
or three domains (Tizard Ian, 1996, Bhattacharya, 2008). 
The amino acid sequence found in the light chain on the N-terminal are different hence 
called the variable light region (VL). Half of the amino acid sequence on the C-terminal 
of each light chain are identical and called the constant light region (CL) with two types 
the kappa (k) and the lambda (λ) light chains (Tizard Ian, 1996, Bhattacharya, 2008). 
Bhattacharya (2008) reported that, in humans, the heavy chain of the IgG consists of 
about 445 amino acids with 115 at the N-terminal and the remaining 330 at the 
constant heavy chain region.  This sequence corresponds to the five different heavy 
chains, alpha (α), epsilon (ε), mu (μ), delta (δ) and gamma heavy chains (γ) to define 





Figure 2: Structure of an immunoglobulin molecule (Tizard Ian, 1996). 
 
There are five major classes of heterodimeric proteins called immunoglobulins (IgA, 
IgD, IgE, IgG and IgM) (Tizard Ian, 1996, Huse et al., 2002).  Immunoglobulins are 
responsible for humoral immunity, which is a branch of the adaptive (specific) immune 
system used largely for adaptive immune memory; opsonisation (identification) of 
foreign pathogenic and parasitic invaders; and neutralization of small invading 
pathogens and toxins (Tizard Ian, 1996, Sommer, 2005, Tizard, 2013, Moticka, 2015, 
Tao and Xu, 2016).  In general, immunoglobulins can be found in serum, on the 
surface of cells, and in secretory fluids such as colostrum, bronchial exudates, saliva, 
and nasal secretions (Lieberman, 2002).  In cats and dogs, IgG and IgA are found in 
high concentration in colostrum, which is the “first mammary secretion rich in 
antibodies” that the kittens and or puppies receive after birth.  IgG is found in higher 
concentrations in feline milk whereas IgA is found in higher concentrations in canine 
milk (Heddle and Rowley, 1975, Casal et al., 1996, Day, 2007). In 1973, (Neoh et al.) 
studied the immunoglobulins of humans, artiodactyls, perissodactyla, proboscidea, 
pinnipedia, lagomorpha, rodentia, marsupalia, and carnivores using chicken antisera.  
Findings of that study showed evidence of high cross-reactivity between species, with 
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every animal tested, including lions and cheetahs, showing profiles predominated by 
IgG (Vaerman et al., 1969, Neoh et al., 1973).  Anti-cat isotype-specific antibodies are 
commercially available to assess cross-reactivity in lions, as they are evolutionarily 
related to cats (Flies et al., 2012). 
1.3.1 Immunoglobulin A 
The discovery of immunoglobulin A (IgA) based on mucosal immunity was introduced 
by Joe Heremans in 1959 (Tomasi, 1992, McDermid et al., 2017).  The individual IgA 
molecules have a molecular weight of 150 kDa (Tizard Ian, 1996).  Immunoglobulin A 
is secreted by plasma cells on the mucosal surfaces of the eyes, mammary glands, 
respiratory tract, skin and urogenital areas for protection against invading 
microorganisms.  It consists of about 10% to 15% of the total serum concentration and 
normally secreted in a dimer form (Tizard Ian, 1996, Bhattacharya, 2008). 
1.3.2 Immunoglobulin D 
The immunoglobulin study from myeloma patients introduced another type of Ig, 
immunoglobulin D (IgD) by David Rowe and John Fahey (Rowe et al., 1973, 
Preud'homme et al., 2000).  Immunoglobulin D is detected in low concentrations in 
plasma, less than 1% of the total serum concentration is found but not in all species. 
Immunoglobulin D together with IgM are expressed by mature B-cells.  
Immunoglobulin D molecule consists of two delta heavy chains and two light chains, 
kappa or lambda chains lacking inter-chain disulphide bonds with a molecular weight 
of about 170 kDa (Tizard Ian, 1996, Bhattacharya, 2008). 
1.3.3 Immunoglobulin E 
 Immunoglobulin E (IgE) was discovered by Kimishige and Teruko Ishizaka in the 
1960s (Ribatti, 2016). The study was based on antibody involving allergic reaction 
releasing histamine and this has led to the findings on treatment for patients with 
allergy and improvement on allergy diagnosis (Johansson, 2011, Ribatti, 2016). 
Immunoglobulin E is found in low concentrations in serum with a molecular weight of 
190 kDa (Tizard Ian, 1996). Immunoglobulin E is made by plasma cells on the surface 
of mast cells in the tissues.  It is found in low concentrations in serum and can only act 
as a signal-transducing molecule. The Fc region binds strongly to receptors on mast 
cells and basophils releasing inflammatory agents such as histamine to eliminate the 
pathogen.  Immunoglobulin E has the shortest half-life of all the immunoglobulins (2 
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to 3 days) and a mild heat treatment can destroy it easily (Tizard Ian, 1996, 
Bhattacharya, 2008). 
1.3.4 Immunoglobulin G 
Immunoglobulin G (IgG) shown in figure 2 is the most common immunoglobulin with 
the highest concentration in serum and plays a major role in the antibody-mediated 
defence mechanisms as a type of passive immunity (Tizard Ian, 1996, Bhattacharya, 
2008).  The structure of IgG (Fc and Fab fragments) was discovered by Rodney Porter 
using the enzyme papain (Porter, 1973).  Gerald Edelman then discovered the four 
chains (heavy and light chains) of immunoglobulins (Porter, 1973, Raju, 1999).  
Immunoglobulin G can also promote phagocytosis by binding to a molecule using Fc 
receptors (opsonisation) (Nezlin, 2017).  It can agglutinate, precipitate antigen and 
activate the pathway of complement when there are sufficient molecules accumulated.  
It has a molecular weight of about 180 kDa and can easily escape from blood vessels 
(Tizard Ian, 1996, Bhattacharya, 2008).  
1.3.5 Immunoglobulin M 
Immunoglobulin M (IgM) is the first immunoglobulin produced among other 
immunoglobulins. The main function of IgM has the ability to bind to multiple foreign 
antigens (Zhou et al., 2007, Ehrenstein and Notley, 2010, Dimitrov et al., 2013) . 
Immunoglobulin M is secreted by plasma cells and found in the second highest 
concentration after the IgG in serum.  It constitutes of about 5% to 10% of the total 
serum concentration.  IgM is made of five monomeric units linked by disulphide bonds 
with a molecular weight of 900 kDa. It is produced in the primary response to an 
antigen and considered as the strongest complement activator, for opsonisation, 








1.4 Development of monoclonal antibodies 
According to Capers (2006), one can use the immunoglobulin purification techniques 
that have been used previously for purifying the immunoglobulin of other species to 
study the immune system of different unstudied species. Commercial antisera 
developed against the immunoglobulins of humans, mice, dogs and sheep are 
available.  These species’ immunoglobulins have been studied in detail and can limit 
the time in developing new antisera (Capers, 2006). 
 
(Cavagnolo and Vedros, 1978, Azwai et al., 1993, Kelly et al., 1998) in their studies 
performed an immunosorbent assay for cross-reactivity using different monoclonal 
and polyclonal antibodies produced against different immunoglobulin classes and 
subclasses of different animals.  There was no cross-reaction between the monoclonal 
antibodies and the immunoglobulin of African elephant (Loxodonta africana) and 
camel (Camelus dromedarius). The polyclonal antibodies cross-reacted with the 
African elephant and camel immunoglobulin, concluding the similarities of African 
elephant and camel immunoglobulin G (IgG) to that of other mammalian species 
(Azwai et al., 1993, Kelly et al., 1998). 
 
Characterization of the IgG is a first step in developing the immunology toolbox in lions 
and further isolate the other antibodies and identify the immune functions of these 
antibodies. One end goal is to develop tools for diagnostic purposes since serology is 
an easy way to survey for disease. The use of serology as a tool for surveillance and 
epidemiological modelling of wildlife diseases has become important hence it is crucial 
to consider the strength and the limitations of serological assays and the interpretation 
of results mostly when using data for prevention and control of infectious diseases in 
wildlife.  The ecology of infectious wildlife diseases has become critical in the animal 
and public health (Gilbert et al., 2013).  In most cases, diseases are often diagnosed 
based on serological tests, as they are effective and simple (Kelly et al., 1993, El-
Hewairy, 2012).  
 
Therefore, in this study we focused on the isolation and characterization of IgG 
(commonly referred to as antibodies) as the major components of HI in lions using 
anti-cat IgG in determining the level of cross-reactivity. Sodium-dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) was further used to determine the 
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molecular weight of lion IgG. These findings will add to the immunology toolbox in 
assessing the health of captive and non-captive individuals and populations. 
 
1.5 Problem statement 
The decrease in wild felid population caused by poaching, drought and diseases such 
as bovine tuberculosis (BTB), FIV and other microbial diseases has disrupted 
conservation programs (Donnelly et al., 2003, Ferreira and Funston, 2010, Maas et 
al., 2010).  Past studies investigating these threats have shown that the Kruger 
National Park (KNP) has a high disease prevalence throughout various regions of the 
park (Antunes et al., 2008, Ferreira and Funston, 2010, Maas et al., 2010, Maas et al., 
2012b, Broughton, 2017).  However, there is unknown or limited information on the 
feline immune system and the diagnostic tests and/or tools are required to increase 
knowledge on wild felid immunoglobulins.   
1.6 Aims and objectives  
The aim of the study is to isolate and characterize lion IgG. 
The objectives of the study are to: 
− Determine cross-reactivity of current or available conjugates with crude and 
purified lion IgG.   
− Purify cat and lion IgG from crude serum.  
− Determine the molecular weight of lion IgG and the molecular weight of both 
the Fc and Fab fragments.  
 
1.7 Hypothesis 
− Goat anti-cat IgG cross-reacts with lion IgG. 
− The IgG molecular weight of lion is similar to the molecular weight of cat IgG.   
 
1.8 Scope of dissertation 
The general purpose of the study is to increase information on the feline immune 
system. There is very little information about the IgG of lions and serological diagnostic 
tests. In 1998 (Kelly et al.) conducted a study on the isolation and characterization of 
African elephant IgG.  The recent study on the hyena immunology toolbox was 
conducted by (Flies et al., 2012) where sera from hyena was purified.  The purified 
IgG was then used for cross-reactivity studies and determination of the molecular 
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weight. In this study, the approach will be similar but limited to the characterization of 
the lion IgG molecule.  
African lion sera from South Africa (KNP and Game Reserve in the North West 
Province) and Zimbabwe were used in the study.  All samples were processed at the 
University of Pretoria, Department of Veterinary Tropical Diseases (DVTD) 
laboratories. The duration of the experimental work was completed in six months.  In 
this study, a direct ELISA is used to determine the percentage of cross-reactivity 
against cat IgG and lion IgG using goat anti-cat IgG (H+L) antibody, horseradish 
peroxidase (HRP) conjugate. The level of cross-reactivity can depend on the crude 
serum dilutions and/or purified IgG and the dilution of the conjugate. The assay is 
limited to quality of samples.  Fresh samples (stored for less than a year) are required 
for pure IgG isolation. Furthermore, the molecular weight of lion IgG is determined by 






CHAPTER 2: MATERIAL AND METHODS  
 
2.1 Study area 
Lion serum samples were obtained from the KNP, a private nature reserve in North 
West province, South Africa and three private reserves in Harare, Zimbabwe as shown 
in figure 3.  The lions in the KNP are free-ranging (roaming freely and hunting for prey) 
whereas they were captive (kept in confined space and fed selected meat) in Harare 
private reserves and in the private reserve based in North West Province.  
 The serum samples from a free-ranging population in the KNP were sourced from a 
biological bank. The serum samples from Zimbabwe were opportunistic samples and 
available to be used in the study with permission granted from the Department of 
Agriculture, Forestry and Fisheries (DAFF). The lions from a private game reserve in 
North West Province had a similar set up to the lions kept in Zimbabwe and serum 
samples were provided to contribute to the research. 
 
Figure 3: Map of South Africa and Zimbabwe (South African National Parks, 2020) 
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2.2 Ethics and biosafety  
The ethics approval for the project was obtained from University of South Africa-
College of Agriculture and Environmental Sciences, Animal Research Ethics 
Committee (UNISA-CAES) with reference number: 2018/CAES/064. Approval was 
also obtained from the University of Pretoria, Animal Ethics Committee (project 
number V023-18). The Section 20 approval for study was obtained from the 
Department of Agriculture, Forestry and Fisheries (DAFF) with reference number 
12/11/1/1/6 (1277) and 12/11/1/1/6 (643) (see appendix). 
 
2.3 Study design and sampling  
Lion serum samples (n=12) from Zimbabwe were collected using 9 ml serum 
vacutainer tubes via venipuncture of the jugular vein. The blood samples were kept 
cool (on ice) during transportation to the laboratory and stored overnight in the fridge 
(4°C).  The next day, the supernatant was separated by centrifugation at 3200 rpm for 
10 minutes and stored at -80°C. Batched samples were transported to the research 
and training laboratories at the Department of Veterinary Tropical Diseases (DVTD), 
University of Pretoria, South Africa on dry ice and immediately stored at -80°C until 
use (Vhoko, 2018).  These samples were initially collected for another study in 2016 
(Vhoko, 2018) and permission was granted by the Department of Agriculture, Forestry 
and Fisheries (DAFF) to use these samples for this project. 
The whole blood samples from all lions captured in the KNP from 2014 to 2018 (n=40) 
were kept cool (4°C) and transported to the Veterinary Wildlife Services laboratory and 
processed within eight hours after collection. Blood samples were centrifuged using 
Hermle centrifuge for 10 minutes at 2500 rpm.  After centrifugation, the supernatant 
(serum) was dispensed in 4 ml cryo tubes using disposable pipettes then stored in 
freezers at -20°C and/or -80°C for future veterinary research projects.  A clean 
disposable pipette was used for each sample to avoid cross contamination. 
Whole blood from lions in a private reserve in the North West Province (n=16) was 
collected and taken to the laboratory for processing in 2019.  The samples were left in 
the fridge for an hour before centrifugation for 10 minutes at 2800 rpm.  The 
supernatant (serum) was then pipetted into cryo tubes and stored in a -20°C freezer 
for a month prior to use.  
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2.4 Source of domestic cat, chicken, rhinoceros and dog serum  
Serum from the donor cat at the Onderstepoort Veterinary Academic Hospital was 
collected and used as a control in the ELISA to determine cross-reactivity.  Chicken 
serum was obtained from the serology laboratory of the DVTD, as a control serum to 
include in the ELISA to determine cross-reactivity. These sources of rhinoceros and 
dog serum samples were included in the ELISA to determine the percentage cross-
reactivity with anti-cat IgG and compare them to the % cross-reactivity of anti-cat IgG 
to lion IgG. 
2.5 Determination of protein concentration in lion, cat and chicken crude 
serum  
The protein concentration of lion, cat and chicken IgG in crude serum was determined 
using the XposeTM Trinean Spectrophotometer. Individual samples were diluted in 
phosphate buffered solution (1XPBS).  The concentration was determined by first 
diluting the serum (1:200) in PBS and then placing 2 µl of this solution on an Xpose 
slide. Phosphate buffered solution was used as a control.  The total protein 
concentration (mg/ml) was determined on the XposeTM Trinean Spectrophotometer 
and the absorbance of the protein was measured at 280 nm. The following calculations 
were used to work out the concentration of serum and IgG. For serum protein 
concentration, 1A280 = 1 mg/ml and for IgG concentration, 1.35A280 = 1 mg/ml. To 
determine the original concentration of the crude serum, the value obtained after the 
measurement was multiplied by the dilution factor (x200).  The total protein and the 
serum concentration of 10 µg/ml were then used to calculate the final serum volume 
using the formula C1V1 /C2V2 as shown in Appendix 3. 
2.6 Determining cross-reactivity of goat anti-cat IgG (H+L) secondary antibody, 
horseradish peroxidase (HRP) conjugate with lion IgG using lion and cat crude 
serum 
To determine cross-reactivity and the optimal coating concentration of the crude 
serum, an in-house direct ELISA was developed.  MaxiSorp™ (Nunc) 96-well plates 
with high protein binding capacity were used.  These plates were coated with different 
concentrations of the crude serum: 10 µg/ml, 5 µg/ml, 2.5 µg/ml and 0 µg/ml. Each 
sample was run eight times.  After coating, the plates were placed in a Biosan 
environmental shaker-incubator ES-20 at 150 rpm for 10 minutes at room temperature, 
and incubated overnight at 4°C.  The coating buffer was discarded the next day, and 
36 
 
the plates were washed twice with a wash buffer (PBS + 0.05% Tween 20) using a 
wash bottle.  Blocking buffer (300 µl 2% fat free milk powder in PBS + 0.05% Tween 
20) was added to the wells of the plates, followed by incubation at 150 rpm for 1 hour 
at 37°C in a shaking incubator.  After incubation, the washing step was repeated.  To 
determine if polyclonal goat anti-cat IgG (H+L) secondary antibody, horseradish 
peroxidase conjugate (Invitrogen) cross-reacted with lion IgG, the conjugate used in 
the ELISA was diluted as follows: 1:10 000 and 1:20 000.  One hundred microliter of 
the conjugate was added.  The incubation step was repeated followed by a wash step 
which was performed five times using the wash buffer.  The liquid substrate 3, 3′,5 ,5′-
Tetramethylbenzidine (100 µl) (TMB, T4444 Sigma-Aldrich) was added to wells of the 
plates and incubated for two minutes.  The reaction was stopped with 50 µl of 2 M 
Sulphuric acid (2M H2SO4). The plates were then read at 450 nm using Biotek Power 
wave XS2 plate reader and the data were exported to an Excel spreadsheet for 
analysis using Gen 5 software.  The results were used to determine the percentage of 
cross-reactivity of the different species serum samples.  The average mean optical 
density (OD) value of each test sample (lion, rhinoceros and chicken) was subtracted 
from the average mean OD value of the negative control (PBS) to determine the final 
OD.  The following formula was used to determine the percentage cross-reactivity of 
the goat anti-cat antibody to lion IgG in crude serum. Cross-reactivity % = Optical 
density of test samples ÷ Optical density of the cat X 100. 
Cross-reactivity % = OD test sample / ODcat  X 100 
2.7 Determination of cross-reactivity of Goat Anti-cat IgG HRP conjugate with 
lion IgG 
To determine cross-reactivity against purified lion IgG using ELISA, the following 
optimal conditions were used for lion and cat IgG as mentioned previously: 1µg/ml, 
0.1 µg/ml, 0.01 µg/ml, 0.001 µg/ml and 0 µg/ml.  A MaxiSorp™ plate was coated with 
purified IgG from lion and cat serum. A similar method as mentioned previously for 
performing ELISA was used. 
2.8 Purification of cat and lion IgG from crude serum 
For the purification of the IgG, a commercial kit, MagReSyn® Protein A magnetic beads 
(ReSyn BiosciencesTM  MR-PRA005, Separations) with strong binding capacity for cat 
IgG was used.  The protocol was followed according to the manufacturer's instructions. 
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The MagReSyn® Protein A was supplied as a 15 mg/ml-1 suspension in TBS (50 mM), 
Tris pH 7.5, 150 mM NaCl with 0.025% Tween® 20 and 0.05% sodium azide as a 
preservative.  The magnetic beads were gently vortexed using Labnet vortex mixer. 
The shipping solution was removed, and magnetic beads equilibrated in binding buffer 
(1 X PBS) before use.  MagReSyn® Protein A magnetic beads were gently vortexed 
and 50 µl was pipetted into four 1.5 ml Eppendorf tubes.  The four tubes were placed 
on a ReSyn BiosciencesTM magnetic separator allowing the magnetic beads to clear.  
The supernatant was discarded.  The Eppendorf tubes containing magnetic beads 
were placed on a rack and 300 µl of binding or wash buffer (1 X PBS) was added and 
incubated at room temperature for one minute, then the supernatant discarded.  The 
washing or binding steps were repeated to a total of three washing or binding steps. 
 
For immunoglobulin purification from lion and cat sera, nine parts binding buffer were 
used to dilute the pooled lion and cat serum samples. Pooled crude lion sera to 
increase the volume required for the purification of the lion IgG samples and cat sera 
were diluted each 1:10 in 1X PBS and 1 ml of this dilution was transferred to four 
Eppendorf tubes with the equilibrated MagReSyn Protein A, sealed with parafilm to 
avoid leakage and incubated at room temperature on a Labnet Rocker 25 at 90 rpm 
for one hour to improve binding efficiency.  After incubation, the tubes were placed on 
a magnetic separator allowing the magnetic beads to clear, the resulting supernatants 
were removed and added to clean tubes before elution.  These supernatants would 
be used to determine the binding efficiency after running the samples on SDS-PAGE.  
The magnetic beads were washed three times with 500 µl of 1 X PBS.  Following each 
wash, the tubes were placed on a magnetic separator allowing the magnetic beads to 
clear.  The supernatant from the three washes were pooled and placed in a tube 
labelled wash step 1 for SDS-PAGE analysis.  
 
Elution of the captured Immunoglobulins 
The captured immunoglobulins were eluted by adding 50 µl of the elution buffer 
(glycine pH 2.8) to the purified MagReSyn Protein A magnetic beads in four Eppendorf 
tubes and mixed thoroughly.  The solution was incubated for 2 minutes allowing the 
captured IgG to elute from the magnetic beads.  The tubes were placed on a magnetic 
separator allowing the magnetic beads to clear.  The supernatants were collected in 
four different elution fractions (elution 1, elution 2, elution 3 and elution 4) containing 
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5 µl of 1 M Tris buffer pH 9.0 to neutralize the reaction.  These fractions would be 
analysed on SDS-PAGE. The magnetic beads were washed 3 times with 1 x PBS.  
The supernatant from the washes were pooled and placed in a tube labelled wash 
step 2 for SDS-PAGE analysis. 
 
Dialysis and concentration of samples 
After the purification of lion IgG using the MegResyn A magnetic beads, 400 µl of the 
eluate was added to a Vivaspin Centrifugal Concentrator (VS0131 - Sartorius Vivaspin 
500, 50 000 MWCO) and the eluate was centrifuged at 11 050 rcf for 10 minutes.  This 
was then followed by the desalting step to remove the buffers used during the elution 
of the IgG from the magnetic beads.  For the desalting step, 450 µl of PBS was added 
to the concentrator, then centrifuged at 11 050 rcf for 10 minutes. The desalting steps 
were performed three times.  After the completion of the desalting steps, the final 
protein concentration was determined using the XposeTM Trinean Spectrophotometer. 
The protein was stored at 4°C until use in the SDS-PAGE analysis.  
 
2.9 SDS-PAGE (Sodium-dodecyl sulfate polyacrylamide gel electrophoresis) 
analysis of the purified lion, cat, dog IgG and lion crude serum  
The SDS-PAGE analysis was performed according to Laemmli (1970). The gels were 
prepared as shown in Table 2. 
 
Table 2: SDS-PAGE gel preparation (Laemmli, 1970) 
8% Separating Gel  Stacking Gel 
Reagents  Volume  Reagents  Volume 
Distilled water 4.6 ml   Distilled water 3.4 ml 
30% Acrylamide mix 2.7 ml  30% Acrylamide  0.83 ml 
1.5M Tris (pH 8.8) 2.5 ml   0.5M Tris (pH 6.8) 0.63 ml 
10% SDS 0.1 ml  10% SDS 0.05 ml 
10% APS 0.1 ml  10% APS 0.05 ml 
TEMED 0.006 ml  TEMED 0.005 ml 
Total Volume  10 ml  Total Volume  5 ml 
 
The gel components were mixed with ammonium persulfate (APS) and 
Tetramethylethylenediamine (TEMED) added before casting the gels.  A gather comb 
was used to make a mark 1 cm beneath the comb.  The acrylamide solution was 
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poured between the glass plates, which were clamped using a casting clamp.  Drops 
of 100% methanol were gently added on the separating gel to break bubbles.  The gel 
was left for 15-30 minutes to polymerize.  The methanol was removed using filter 
paper. The stacking gel was prepared, poured on top of the polymerized separating 
gel, followed by placing the comb into the gel and allowing it to set for 15 to 30 minutes. 
The comb was gently removed before 3 µl of the two protein markers were loaded in 
the first two lanes, the Pink Plus Prestained Protein Ladder (Gene DireX, 500 µl 
volume) stored in a fridge and the Blue protein Standard Broad Range Ladder, 
molecular weight marker (Bio labs, 500 µl volume) stored in a freezer. Then 3 µl of 
each of the prepared samples were added directly into the lanes using 10 µl Eppendorf 
pipette and tips.  The 8% SDS-PAGE gel was vertically placed in a tank with running 
Tris-Glycine electrophoresis buffer on ice.  Electrophoresis was then carried out using 
Bio-Rad Mini-Protean Tetra System and Wealtec Elite 200 power supply at 60V until 
the dye in the sample buffer reached the bottom of the gel, approximately 1 hour and 
30 minutes.  The gel was gently removed from the glass plates, placed on a clear 
open-top flask then washed with distilled water for 15 minutes on a reciprocating 
shaker (FINEPCR, SH30L Reciprocating Shaker).  After 15 minutes, GelCode™ Blue 
Stain Reagent 24590gel code blue stain (Thermo Scientific™) was used to stain the 
gel and placed on a reciprocating shaker for an hour.  The stain was discarded safely 
following lab protocols for hazardous substances and the gel was gently washed with 
distilled water for 15 minutes on a reciprocating shaker. The gel incubated overnight 
at room temperature in distilled water on a reciprocating shaker for complete de-
staining.  The gel was then viewed on Univetec Cambridge transilluminator for visible 
bands, and then placed on a Biorad molecular image gel document system using the 
Image Lab software for analysis.   
Preparation of samples 
Xpose™ Trinean Spectrophotometer was used to determine the protein concentration 
of purified lion IgG. The final concentration of protein loaded in the wells of the SDS-
PAGE was 2 µg/µl. The samples were diluted with loading buffers, one for reduced 
(protein solvent buffer) and the other for non-reduced (6 x agarose loading gel) 
samples, to a final concentration of 2 µg/µl as the optimal.  The reduced, diluted 
samples were each placed in 2 ml Eppendorf tubes, placed on a heating block (Labnet 
Accublock Digital Dry Bath) at 100°C for 10 minutes and centrifuged using Wealtec E-
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Centrifuge for 10 seconds at 3000 rpm.  The non-reduced diluted samples were each 
placed in a 2 ml Eppendorf tubes.  All the samples and protein markers were kept on 
ice during the preparation step.  
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CHAPTER 3: RESULTS 
 
3.1 Determination of protein concentration in lion, cat and chicken crude 
serum and purified IgG 
The Xpose™ Trinean Spectrophotometer software measured the protein 
concentration at an absorbance (OD) of 280 nm.  The protein concentration (lion, cat, 
rhinoceros, chicken crude sera, lion IgG, cat IgG and dog IgG) was determined by the 
use of the Nova Biostorage Xpose™ Trinean Spectrophotometer, then further used to 
determine dilutions of ELISA and SDS-PAGE analysis (Appendix 3). The protein 
concentrations of the purified IgG were used for SDS-PAGE analysis as follows: lion 
IgG (39.09 mg/ml), cat IgG (2.83mg/ml), dog IgG (1.60 mg/ml) and lion crude serum 
(72.6mg/ml).  
3.2 Determination of cross-reactivity of goat anti-cat IgG HRP conjugate with 
lion IgG and other species 
A direct ELISA was used to determine cross-reactivity of the commercial goat anti-cat 
IgG (H+L) antibody to crude lion serum, as well as other animal species.  All the lion 
and cat crude sera were included in the ELISA to determine if anti-cat antibody cross-
reacted with the lion sera.  The cross-reactivity was subjected to coating concentration 
of 10 µg/ml and 1:20 000 of the goat anti-cat IgG (H+L) antibody, HRP conjugate. As 
expected, the conjugate detected IgG in cat serum and cross-reacted with crude 
individual lion sera.  High cross-reactivity was observed ranging between 87.7-100% 
and low reactivity with rhinoceros (22.4%) and chicken (0.01%) (Tables 3). 
3.3 Determination of cross-reactivity of goat Anti-cat IgG HRP conjugate with 
purified lion IgG 
The purified IgG from pooled lion sera and purified IgG from cat serum were also 
tested for cross-reactivity. The goat anti-cat IgG (H+L) antibody cross-reacted with lion 






Table 3: Cross-reactivity of goat anti-cat immunoglobulin IgG with other animal 
species crude sera  
Animal                                          OD450nm                                                 % 
Domestic cat  2.2                                                100.0 
Lion5 2.3 103.7 
Lion2 2.3 101.1 
Lion7 2.2 99.2 
Lion3 2.2 99.2 
Lion4 2.2 99.0 
Lion6 2.2 98.6 
Lion 1 2.2 98.4 
Lion18 2.2 98.3 
Lion22 2.1 95.9 
Lion21 2.1 95.4 
Lion23 2.1 95.1 
Lion 17 2.1 93.7 
Lion 20 2.1 93.2 
Lion 24 2.1 92.9 
Lion19 2.0 87.7 
Rhinoceros 0.5 22.4 







3.4 Purification of cat and lion IgG from crude serum 
Immunoglobulin G from cat and pooled lion serum samples were successfully purified 
and captured using MagReSyn® Protein A magnetic beads.  The supernatant from 
before elution, the wash steps and elution fractions were read spectrophotometrically, 
and this indicated higher protein concentrations in the elution fraction and very low 
protein concentrations in both wash steps (wash step 1 and 2) as indicated in Table 
4. 
Table 4: Protein concentrations of different fractions collected during the purification 
step of cat and lion IgG  
  CAT-APRIL CAT-MARCH KNP Lions Zim Lions 
  Protein (mg/ml) 
Glycine - - - - 
Before Purification 9.58 - 9.67 14.6 
Before Elution 3.7 - 7.72 6.88 
Wash Step 1 0.1 - 0.27 0.22 
Wash Step 2 0 - 0 0.01 
1E1 0.02 1.82 1.06 0.69 
1E2 1.88 2.23 3.11 2.98 
1E3 0.5 0.58 0.73 0 
2E1 - 1.88 1.09 1.55 
2E2 1.25 2.39 0 2.54 
2E3 0.27 0.73 0.92 0.05 
3E1 2.39 3.2 2.12 1 
3E2 1.69 0.73 0.58 3.01 
3E3 - 0.14 0.13 0.64 
4E1 0.9 2.31 1.28 1.37 
4E2 0 2.24 3.14 0 
4E3 0.73 0.49 0.63 0.77 
 
3.5 Characterization of lion, cat and dog IgG on SDS-PAGE 
A molecular weight marker (Blue Stain Standard Broad Range) was used in the PAGE 
gel to determine the molecular weight of lion IgG (Capers, 2006, Sambrook and 
Russell, 2006). The basic structure of Ig consists of disulphide bonds and four 
polypeptide chains, the two light chains (L) and two heavy chains (H) containing 
variable regions (VH or VL) at the N terminal (Neoh et al., 1973, Huse et al., 2002, 
Bhattacharya, 2008, Schroeder Jr and Cavacini, 2010).  During SDS-PAGE analysis, 
heat and reducing agent (protein solvent buffer) were used to denature the proteins of 
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the purified IgG of lion, cat and dog. Under reducing condition, the disulphide bonds 
between the light and heavy chains dissociated, resulting in heavy chain band at the 
top and the light chain band migrating to the bottom of the lane according to the size 
of the polypeptide.  The lion and cat IgG heavy chains were found to be in the same 
range (54- 56 kDa).  The dog IgG heavy chain was found to be smaller than the heavy 
chain of both the lion and cat IgG, estimated to be 48-50 kDa.  The cat IgG light chain 
was estimated at 26-29 kDa.  It was found to be larger than the lion IgG and dog IgG 
light chains estimated at 24-26 kDa and 22-25 kDa.  For the non-reduced samples, 
the disulphide bonds were reformed resulting in a single band.  The band was then 
used to determine the molecular weight of lion IgG and compare it to the molecular 
weight of cat and dog IgG. The lion samples revealed a protein band estimated to be 
between 150-160 kDa and noted to be larger than the heavy chain for both cat and 
dog. The cat and dog samples produced 135-145 kDa and 100-105 kDa bands 
respectively under non-reducing conditions. See Table 5 for summary of molecular 
weights. 
 
Table 5: Molecular weights (kDa) of lion and other species under reduced and non-
reduced conditions  
  Molecular weights (kDa) 
Target Lion  Cat  Dog 
RC-Heavy chain  54-56  54-56  48-50 
RC-Light chain  24-26 26-29 22-25 
Non-reduced condition  150-160 135-145 100-105 





Figure 4:  8% SDS-PAGE Gel: SDS-PAGE analysis of purified lion IgG (L) 
compared to cat IgG (C), Dog IgG (D) and lion crude serum (LCS)  
Lane 1: Pink Plus Prestained Protein Ladder, Lane 2: Blue Protein Standard Broad 
Range Ladder, Lane 3: Reduced Lion IgG (LR), Lane 4: Non-Reduced Lion IgG (LNR), 
Lane 5: Reduced Cat IgG (CR), Lane 6: Non-Reduced Cat IgG (CNR), Lane 7: 
Reduced Dog IgG (DR), Lane 8: Non-Reduced Dog IgG (DNR), Lane 9: Reduced Lion 
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CHAPTER 4: Discussion 
 
Ferreira and Funston (2010) have reported a decrease in wild felid populations caused 
by poaching, drought and infectious diseases such as BTB, FIV disease and other 
pathogenic diseases, whereas Green et al. (2020) have stated that there is an 
expansion in farms breeding lions which have created the opportunity for an increase 
of emerging zoonotic diseases.  
In view of the above, the understanding of the immune mechanisms that may underlie 
disease susceptibility and provide protection against large-scale population crashes in 
the face of disease outbreaks has become crucial especially with the advent of the 
Covid-19 pandemic.  According to Capers (2006), one can use the immunoglobulin 
purification techniques that have been used previously for purifying the 
immunoglobulin of other species to study the immune system of different unstudied 
species.  Immunoglobulin IgG plays an important role in the protection against 
diseases and can be a good indicator of immunological responses to infectious 
challenges.   
The aim of this study was the isolation and characterization of lion IgG as little is known 
about the lion immune system.  Several objectives were formulated, and results 
obtained are discussed. 
The use of the Nova Biostorage Xpose™ Trinean Spectrophotometer was used 
successfully to determine the protein concentration of crude serum and purified IgG. 
It was observed that fresh serum samples (less than a year) have higher protein 
concentration compared to the samples that were stored more than two years.  Indeed, 
there are different factors that may influence the concentration levels of 
immunoglobulins which include age, disease condition and storage in the laboratory.  
The concentration of purified IgG does not deteriorate when stored at -20°C.  In this 







Cross-reactivity was observed using an in-house direct ELISA, the OD values are 
shown in Tables 3.  A strong reactivity was observed between the goat anti-cat IgG 
with the lions’ IgG, the highest percentage of cross-reactivity range between 87.7-
100% whereas the low cross-reactivity were observed with rhinoceros (22.4%) and 
chicken (0.01%). These results confirm the phylogenetic relationship between 
domestic cat and lion.  Since cat and lions are genetically related, cross-reactivity was 
expected at higher percentage with both crude sera and purified IgG in the study 
compared to the chicken sera which was included as a control sample in the ELISA.  
The study indicates a strong antigenic similarity between cat and lion and a more 
distant relationship when felids are compared with chicken. In general, species that 
are genetically related, show a very strong antigenic similarity and a very weak 
similarity if not related (Kania et al., 1997, Capers, 2006).  Detecting antibodies in the 
sera of wild felids using anti-cat IgG is standard procedure (Penzhorn et al., 2002). 
It is also worth noting that there was 22.4 % cross-reactivity with rhinoceros crude 
serum, although this specie is out of the felid family.  These results indicate that the 
goat anti-cat IgG was specific to the rhinoceros to some extent.  Perhaps, the antigenic 
determinants of IgG region of cat and rhinoceros do share homologues in the amino 
acid sequence of the antigen.  Since rhinoceros and lion are both endangered species 
in South Africa, further investigation on the antigenic determinant of the 
immunoglobulin responsible for cross-reactivity could be explored.  Immunoglobulins 
are useful as labelled secondary antibodies in immunoassays, it is therefore important 
to detect any cross-reactivity with other species to prevent false positive reactions 
(Ramlau, 1987). 
The IgG isolated by the usage of MagReSyn® Protein A magnetic beads from ReSyn 
Biosciences confirmed a highly enriched IgG. The MagReSyn® Protein A has strong 
binding capacity for cat, dog, pig, rabbit and guinea pig IgG and was found to be 
effective for capturing the proteins from the lion sera and lion IgG (ReSyn-Biosciences, 
2012-2017). 
The results of the SDS-PAGE analysis provided us with the tool to determine the 
molecular mass of lion IgG. For the cat heavy chain the molecular weight is between 
54-56 kDa which is in the same range (50-59 kDa) as shown in other studies (Grant, 
1995, Yamada et al., 2007, Flies et al., 2012).  According to the summary provided by  
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Flies et al. (2012), the molecular weight of cat heavy chain ranges from 50 to 59 kDa 
and light chains at 22 to 28 kDa. The molecular weight of dog IgG heavy and light 
chains ranges respectively from 50-55 kDa and 20-31 kDa (German et al., 1998, 
Donaghy and Moore, 2020), whereas in this study the molecular weight of both chains 
were respectively 48-50 kDa and 22-25 kDa. The molecular weight of lion IgG is larger 
than the molecular weight of cat IgG. IgG is the most common immunoglobulin with 
the highest concentration in serum and plays a major role in the antibody-mediated 
defence mechanisms as a type of passive immunity (Tizard Ian, 1996, Bhattacharya, 
2008). The lion immunoglobulin is also found to be closely similar to the 
immunoglobulins of other Felidae (domestic cat) and Canidae (spotted hyena and 
domestic dog) (Yamada et al., 2007, Flies et al., 2012).  
SDS-PAGE is the simplest and least expensive and most used technique to analyse 
antibodies for purity. On SDS-PAGE, the reduced samples of IgG class of antibodies 
provide heavy chains of approximately 50 kDa and light chains of approximately 25 
kDa.  When these samples are analysed without reduction of disulphide bonds, the 
antibodies should give rise to a single band where the intact antibody consisting of two 
heavy and two light chains, with a combined size of approximately 150 kDa (Kirley and 
Norman, 2018).  In this study, the non-reduced lion IgG sample size of the molecule 
is estimated to be between 150-160 kDa. 
Tizard Ian (1996) stated that IgG is the smallest of the immunoglobulin classes with a 
molecular weight of 180 kDa and can easily escape from blood vessels and play an 
important role in passive immunity. Our results have shown that the molecular weight 
of the IgG is 150-160 kDa.  This may suggest that the lion maternal passive immunity 
to the foetus within natural habitat might be high.  
SDS-PAGE has been widely used to characterize IgG of other mammalian species 
and the results have been proven to be consistent with the results of western blotting 
technique (Capers, 2006, Yamada et al., 2007, Flies et al., 2012).  To our knowledge, 
besides the study conducted by Flies et al. (2012) on hyena immunology, there are no 
studies that determined the molecular weight of lion IgG.   
Basic immunology tools can be used in studying the immune function in different 








The objectives of the study as set out were achieved within the time constraint. 
5.1.1 Determine cross-reactivity of current or available antibodies with lion 
IgG.   
The concentration of protein in the crude sera from different species was determined.  
There was cross-reactivity, high similarity was observed between cat and lion. The 
percentage of cross-reactivity dropped with other species as the species are not 
genetically related to lion.    
5.1.2 Purify cat and lion IgG from crude serum.  
The usage of the MagReSyn® Protein A magnetic beads from ReSyn Biosciences 
was effective for purification of lion IgG with a superior binding capacity. Cross-
reactivity of purified IgG and crude sera was observed on ELISA using Goat anti-cat 
IgG.  
5.1.3 Determine the molecular weight of lion IgG and the molecular weight of 
both the Fc and Fab fragments. 
The molecular weight from purified lion Ig was characterized on SDS-PAGE and 
successfully measured.  The lion and cat IgG heavy chain were found to be in the 
same range (54- 56 kDa). The dog IgG was slightly smaller than the heavy chain of 
both the lion IgG and cat IgG, estimated to be 48-50 kDa. 
 
5.2 Research challenges 
• Old sera did not yield any protein most likely due to denaturation of proteins 
during a long storage whereas the fresh sera yielded a high concentration of 
proteins (IgG) which allowed the characterization of proteins.  
• The isolation and characterization of the lion immunoglobulin was laborious and 
difficult process, the handling of the gel was a delicate technique to master. 
• Lion IgG is large and could not be fully characterized using SDS PAGE.  
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5.3 Future perspectives 
5.3.1. There are some activities that have derived from this research, which will be 
carried out for publication purposes.  These activities will be planned as short, medium 
and long-term goals. 
5.3.2. All bioassays related to this research project were conducted in vitro.  There is 
still a need for the development of anti-lion antibodies in vivo using laboratory 
animals/other small animal species as these anti-lion antibodies are not commercially 
available. 
5.3.3. Isolation and sequencing of whole IgG genome from lions in captivity and semi-
captivity.  
5.3.4. Comparing immunoglobulins profile of captive and/or free-ranging lions from 
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Appendix 1: Lion (KNP and Zimbabwe) and Cat Elution Fractions from crude serum 
  Position Sample name Protein (mg/ml) E1% Impurities (A280) Background (A280) Residue (%) A280 A260/A280 
Glycine  A1 blank_A1 - - - 0.08 - 0 - 
E1 Cat B1 sample_B1 - 10 - - - - - 
E2 Cat C1 sample_C1 1.56 10 0.01 0.08 0.4 1.59 0.53 
E3 Cat D1 sample_D1 1.8 10 0 0.21 0.6 1.8 0.52 
E4 Cat E1 sample_E1 1.65 10 0 0.37 0.5 1.66 0.53 
E1 Lion  F1 sample_F1 1.55 10 0.01 0.28 0.6 1.58 0.51 
E2 Lion  G1 sample_G1 1.91 10 0.22 0.01 1.6 2.15 0.58 
E3 Lion  H1 sample_H1 1.58 10 0.01 0.11 0.8 1.6 0.52 







Appendix 2: ELISA results for Cross-reactivity between cat and lion IgG 
  Cat Lion 
Dilutions 1 2 3 4 5 6 µ OD 7 8 9 10 11 12 µ OD 
1 µg/ml 2.619 2.568 2.487 2.54 2.531 2.557 2.550 2.463 2.366 2.324 2.379 2.332 2.329 2.387 2.353 2.300 
0.1 µg/ml 1.491 1.403 1.473 1.473 1.456 1.424 1.453 1.366 1.152 1.103 1.093 1.127 1.159 1.188 1.137 1.085 
0.01 µg/ml 0.299 0.287 0.3 0.282 0.31 0.303 0.297 0.209 0.198 0.205 0.212 0.204 0.215 0.226 0.210 0.158 
0.001 
µg/ml 
0.128 0.09 0.092 0.078 0.145 0.083 0.103 0.015 0.067 0.061 0.063 0.061 0.062 0.061 0.063 0.010 
















Appendix 3: Summary of protein concentration and cross-reactivity of lions, cat and chicken crude serum. 




(mg/ml) Final Volume Final Volume (ml) 
Anti-cat ELISA 
Average  
Repeats Anti-cat ELISA 
Average  OD  
        
Lion 1 0.39 78 0.26 2 2.25 2.07 2.2 
Lion 2 0.42 84 0.24 2 2.31 0 2.26 
Lion 3 0.55 110 0.45 5 2.27 0 2.22 
Lion 4 0.41 82 0.24 2 2.26 0 2.21 
Lion 5 0.46 92 0.22 2 2.37 0 2.32 
Lion 6 0.42 84 0.24 2 2.25 0 2.21 
Lion 7 0.36 72 0.28 2 2.27 0 2.22 
Lion 8 0.25 50 0.4 2 2.24 0 2.19 
Lion 9 0.34 68 0.29 2 2.28 0 2.23 
Lion 10 0.38 76 0.26 2 2.25 0 2.2 
Lion 11 0.33 66 0.3 2 2.23 0 2.19 
Lion 12 0.35 70 0.29 2 2.24 0 2.19 
Lion 13 0.49 98 0.2 2 2.3 0 2.25 
Lion 14 0.42 84 0.24 2 2.18 0 2.14 
Lion 15 0.39 78 0.26 2 2.24 0 2.19 
Lion 16 0.34 68 0.29 2 2.28 0 2.24 
Lion 17 0.33 66 0.3 2 2.14 0 2.1 
Lion 18 0.51 102 0.49 5 2.24 0 2.2 
Lion 19 0.31 62 0.32 2 2.01 0 1.96 
Lion 20 0.36 72 0.28 2 2.13 0 2.09 
Lion 21 0.25 50 0.4 2 2.18 0 2.13 
4 
 
Lion 22 0.25 50 0.4 2 2.19 0 2.15 
Lion 23 0.33 66 0.3 2 2.17 0 2.13 
Lion 24 0.33 66 0.3 2 2.12 0 2.08 
Lion 25 0.53 106 0.47 5 2.28 0 2.23 
Lion 26 0.38 76 0.26 2 2.28 0 2.23 
Lion 27 0.38 76 0.26 2 2.28 0 2.24 
Lion 28 0.4 80 0.25 2 2.33 0 2.28 
Lion 29 0.32 64 0.31 2 2.41 0 2.36 
Lion 30 0.41 82 0.24 2 2.4 0 2.36 
Lion 31 0.34 68 0.29 2 2.27 0 2.33 
Lion 32 0.22 44 0.45 2 1.39 1.32  1.34 
Lion 33 0.33 66 0.3 2 2.3 0 2.25 
Lion 34 0.48 96 0.21 2 2.33 0 2.28 
Lion 35 0.48 96 0.21 2 2.27 0 2.22 
Lion 36 0.36 72 0.28 2 2.27 0 2.22 
Lion 37 0.43 86 0.23 2 2.26 0 2.21 
Lion 38 0.5 100 0.2 2 2.33 0 2.28 
Lion 39 0.44 88 0.23 2 2.28 0 2.23 
Lion 40 0.36 72 0.28 2 2.26 0 2.21 
ZimLion 1 1.55 310 0.32 10 1.74 2.02 1.96 
ZimLion 2 0.41 82 0.24 2 1.86 2.1 2.04 
ZimLion 3 0.4 80 0.25 2 1.91 2.09 2.03 
ZimLion 4 0.54 108 0.46 5 1.85 2.03 1.97 
ZimLion 5 0.59 118 0.42 5 1.89 2.03 1.98 
ZimLion 6 0.45 90 0.2 2 1.99 2.13 2.08 
ZimLion 7 0.62 124 0.4 5 1.77 1.98 1.92 
ZimLion 10 0.37 74 0.27 2 1.67 1.86 1.8 
ZimLion 11 0.33 66 0.3 2 1.87 1.93 1.87 
ZimLion 12 0.43 86 0.23 2 1.86 1.93 1.88 
5 
 
ZimLion 13 0.63 126 0.4 5 1.83 1.91 1.85 
ZimLion 14 0.36 72 0.28 2 1.87 1.93 1.87 
Cat 0.25 50 0.8 2 2.14 0 2.14 
Rhino 0.9 180 0.27 5 0.51 0 0.5 
Chicken  0.25 50 0.8 2 0.05 0 0 
PBS 0 0 0 0 0.05 0 0 
 
Appendix 4: ELISA results for Cross-reactivity between cat, lion, chicken and rhino crude serum  
10 µg/ml             
1:20 000 
Conjugate  
Cat Rhino Chicken Lion1 Lion 2 Lion 3 Lion 4 Lion5 Lion6 Lion7 Lion8 Negative  
A 2.22 0.55 0.05 2.28 2.25 2.32 2.27 2.30 2.29 2.28 2.30 0.05 
B 2.27 0.54 0.05 2.17 2.35 2.31 2.23 2.34 2.24 2.30 2.27 0.04 
C 2.28 0.55 0.05 2.28 2.29 2.23 2.14 2.53 2.21 2.21 2.23 0.05 
D 2.19 0.53 0.05 2.15 2.33 2.18 2.15 2.22 2.28 2.29 2.16 0.04 
E 2.30 0.54 0.05 2.22 2.28 2.19 2.34 2.23 2.21 2.21 2.20 0.05 
F 2.40 0.56 0.05 2.26 2.27 2.28 2.40 2.71 2.19 2.28 2.21 0.05 
G 2.36 0.55 0.05 2.29 2.33 2.28 2.27 2.28 2.29 2.32 2.21 0.07 
H 2.35 0.57 0.05 2.34 2.38 2.37 2.30 2.34 2.34 2.26 2.35 0.04 
Mean  2.2951 0.5475 0.0471 2.2494 2.3118 2.2683 2.2628 2.3685 2.2548 2.2686 2.2419 0.0490 
OD 2.2461 0.4985 -0.0019 2.2004 2.2628 2.2193 2.2138 2.3195 2.2058 2.2196 2.1929 0.0000 
              
10 µg/ml             
1:20 000 
Conjugate  
Cat Rhino Chicken Lion 9 Lion 10 Lion 11 Lion 12 Lion 13 Lion 14 Lion 15 Lion 16 Negative  
A 2.25 0.55 0.05 2.28 2.43 2.34 2.35 2.35 2.21 2.32 2.19 0.04 
B 2.30 0.55 0.05 2.22 2.22 2.48 2.22 2.25 2.24 2.23 2.13 0.04 
C 2.28 0.54 0.05 2.16 2.24 2.22 2.21 2.21 2.08 2.21 2.21 0.05 
D 2.21 0.52 0.05 2.30 2.14 2.17 2.14 2.28 2.16 2.20 2.22 0.05 
6 
 
E 2.28 0.54 0.05 2.31 2.13 2.19 2.20 2.22 2.14 2.19 2.50 0.06 
F 2.30 0.55 0.05 2.29 2.38 2.19 2.23 2.35 2.21 2.18 2.47 0.05 
G 2.24 0.54 0.05 2.30 2.16 2.11 2.23 2.33 2.18 2.25 2.27 0.04 
H 2.31 0.55 0.04 2.37 2.29 2.18 2.32 2.39 2.22 2.32 2.29 0.03 
Mean  2.2716 0.5414 0.0476 2.2794 2.2464 2.2344 2.2371 2.2978 2.1803 2.2364 2.2824 0.0449 
OD 2.2268 0.4965 0.0028 2.2345 2.2015 2.1895 2.1923 2.2529 2.1354 2.1915 2.2375 0.0000 
             
             
10 µg/ml             
1:20 000 
Conjugate  
Cat Rhino Chicken Lion 17 Lion 18 Lion 19 Lion 20 Lion 21 Lion 22 Lion 23 Lion 24 Negative  
A 2.33 0.57 0.05 2.19 2.32 2.09 2.17 2.22 2.29 2.25 2.10 0.05 
B 2.27 0.55 0.05 2.23 2.31 2.06 2.15 2.98 2.23 2.19 2.10 0.05 
C 2.31 0.53 0.05 2.19 2.32 2.04 2.16 2.11 2.24 2.22 2.14 0.04 
D 2.23 0.56 0.05 2.11 2.21 2.01 2.17 2.05 2.07 2.12 2.13 0.04 
E 2.22 0.54 0.05 2.07 2.26 1.96 2.09 1.98 2.10 2.21 2.12 0.04 
F 2.26 0.55 0.05 2.16 2.14 1.93 2.13 2.02 2.23 2.05 2.14 0.04 
G 2.27 0.52 0.05 2.07 2.16 1.97 2.05 2.03 2.17 2.15 2.13 0.05 
H 2.30 0.56 0.05 2.11 2.22 1.99 2.12 2.06 2.21 2.20 2.14 0.04 
Mean 2.2728 0.5469 0.0469 2.1410 2.2434 2.0068 2.1300 2.1783 2.1909 2.1728 2.1226 0.0446 
OD 2.2281 0.5023 0.0023 2.0964 2.1988 1.9621 2.0854 2.1336 2.1463 2.1281 2.0780 0.0000 
             
10 µg/ml             
1:20 000 
Conjugate  
Cat Rhino Chicken Lion 25 Lion 26 Lion 27 Lion 28 Lion 29 Lion 30 Lion 31 Lion 32 Negative  
A 2.43 0.61 0.05 2.39 2.31 2.33 2.38 2.48 2.52 2.39 0.67 0.04 
B 2.40 0.59 0.05 2.23 2.34 2.33 2.34 2.32 2.33 2.35 1.52 0.04 
C 2.47 0.60 0.05 2.33 2.27 2.42 2.37 2.38 2.62 2.30 1.47 0.05 
D 2.48 0.58 0.05 2.27 2.23 2.26 2.41 2.49 2.32 2.37 1.53 0.05 
E 2.30 0.58 0.05 2.28 2.22 2.23 2.31 2.41 2.32 2.25 1.44 0.05 
F 2.38 0.59 0.05 2.23 2.31 2.24 2.32 2.41 2.35 2.50 1.41 0.06 
7 
 
G 2.41 0.57 0.05 2.23 2.29 2.25 2.23 2.47 2.38 2.37 1.59 0.05 
H 2.45 0.58 0.06 2.28 2.24 2.21 2.25 2.30 2.37 2.47 1.46 0.05 
Mean 2.4140 0.5860 0.0499 2.2778 2.2754 2.2836 2.3256 2.4064 2.4016 2.3731 1.3856 0.0489 
OD 2.3694 0.5414 0.0053 2.2331 2.2308 2.2390 2.2810 2.3618 2.3570 2.3285 1.3410 0.0043 
             
10 µg/ml             
1:20 000 
Conjugate  
Cat Rhino Chicken Lion 33 Lion 34 Lion 35 Lion 36 Lion 37 Lion 38 Lion 39 Lion 40 Negative  
A 2.25 0.57 0.06 2.40 2.36 2.31 2.34 2.35 2.35 2.32 2.25 0.04 
B 2.24 0.51 0.04 2.24 2.28 2.21 2.29 2.25 2.33 2.26 2.29 0.05 
C 2.20 0.51 0.04 2.28 2.39 2.18 2.27 2.25 2.31 2.30 2.31 0.07 
D 2.20 0.52 0.04 2.20 2.42 2.21 2.29 2.27 2.34 2.28 2.26 0.04 
E 2.17 0.53 0.04 2.40 2.23 2.20 2.21 2.18 2.28 2.26 2.20 0.05 
F 2.17 0.51 0.04 2.36 2.38 2.23 2.30 2.36 2.38 2.28 2.23 0.05 
G 2.17 0.57 0.04 2.29 2.26 2.58 2.22 2.15 2.28 2.25 2.29 0.06 
H 2.16 0.51 0.04 2.25 2.31 2.24 2.25 2.29 2.34 2.30 2.28 0.04 
Mean  2.1951 0.5298 0.0414 2.3016 2.3290 2.2690 2.2706 2.2626 2.3259 2.2795 2.2641 0.0499 
OD 2.1453 0.4799 -0.0085 2.2518 2.2791 2.2191 2.2208 2.2128 2.2760 2.2296 2.2143 0.0000 
              
10 µg/ml             
1:20 000 
Conjugate  


















A 1.81 0.43 0.04 1.80 1.83 1.88 1.79 1.85 1.93 1.77 1.65 0.05 
B 1.89 0.41 0.04 1.72 1.90 1.88 1.97 1.92 1.92 1.77 1.63 0.04 
C 1.88 0.42 0.04 1.75 1.94 1.88 1.80 1.87 1.90 1.77 1.63 0.05 
D 1.80 0.42 0.04 1.72 1.85 1.96 1.87 1.86 1.99 1.74 1.72 0.04 
E 1.80 0.42 0.04 1.77 1.81 1.95 1.81 1.87 2.01 1.78 1.66 0.05 
F 1.83 0.44 0.04 1.74 1.83 1.90 1.80 1.87 1.98 1.79 1.74 0.05 
G 1.81 0.42 0.04 1.71 1.83 1.90 1.87 1.95 2.17 1.75 1.66 0.04 
H 1.81 0.42 0.04 1.74 1.85 1.95 1.87 1.96 2.00 1.79 1.73 0.04 
Mean 1.8288 0.4226 0.0393 1.7421 1.8550 1.9113 1.8469 1.8939 1.9866 1.7701 1.6740 0.0460 
8 
 
OD 1.7828 0.3766 -0.0067 1.6961 1.8090 1.8653 1.8009 1.8479 1.9406 1.7241 1.6280 0.0000 
             
             
10 µg/ml             
1:20 000 
Conjugate  















Lion 32 Negative 
A 2.08 0.47 0.04 2.00 1.88 1.83 1.85 1.81 1.89 1.82 1.22 0.04 
B 1.95 0.45 0.15 1.89 1.76 1.82 1.82 1.80 1.87 1.74 1.16 0.03 
C 2.04 0.46 0.04 1.84 1.87 1.80 1.77 1.80 1.79 2.02 1.17 0.04 
D 2.04 0.48 0.03 1.79 1.81 1.83 1.79 1.75 1.81 1.82 1.21 0.04 
E 2.01 0.49 0.04 1.82 1.82 1.83 1.81 2.20 1.81 1.86 1.20 0.05 
F 1.98 0.47 0.04 1.82 1.91 1.95 1.74 1.80 1.92 1.84 1.26 0.07 
G 1.98 0.47 0.04 1.90 1.87 1.87 1.79 1.79 1.82 2.03 1.24 0.05 
H 2.02 0.52 0.04 1.93 1.91 1.96 1.86 1.84 2.00 1.91 1.28 0.05 
Mean 2.0124 0.4749 0.0514 1.8740 1.8520 1.8610 1.8023 1.8473 1.8624 1.8790 1.217 0.045 














cat ELISA    1 2 3 4 5 6 7 8 9 10 11 12 
1:20 000 
conjugate    
cat 













A 10 µg/ml 1.99 0.50 0.06 2.22 1.37 2.06 2.15 2.17 2.08 2.07 2.14 0.05 
B 10 µg/ml 2.04 0.50 0.05 2.16 1.33 2.07 2.17 2.17 2.05 2.05 2.13 0.05 
C 10 µg/ml 2.00 0.49 0.05 0.05 1.33 2.04 2.12 2.12 2.07 2.08 2.12 0.04 
D 10 µg/ml 2.03 0.46 0.06 2.14 1.32 2.01 2.13 2.08 2.03 2.01 2.11 0.10 
E 10 µg/ml 1.99 0.48 0.06 2.07 1.30 2.02 2.14 2.04 1.99 1.98 2.11 0.05 
F 10 µg/ml 2.04 0.47 0.05 1.97 1.32 2.07 2.02 2.03 2.03 2.03 2.25 0.05 
G 10 µg/ml 1.98 0.46 0.05 2.06 1.28 1.93 2.01 2.00 1.99 2.03 2.11 0.05 
H 10 µg/ml 2.03 0.48 0.06 2.07 1.29 1.93 2.04 2.09 1.98 2.03 2.12 0.05 
Mean  10 µg/ml 2.0133 0.4796 0.0526 2.0985 1.3161 2.0154 2.0978 2.0878 2.0266 2.0341 2.1349 0.0538 
OD 10 µg/ml 1.9595 0.4259 -0.0011 2.0448 1.2624 1.9616 2.0440 2.0340 1.9729 1.9804 2.0811 0.0000 
    
            
              
Plate 14 anti-
cat ELISA    1 2 3 4 5 6 7 8 9 10 11 12 
1:20 000 
conjugate    
cat 













A 10 µg/ml 2.02 0.48 0.04 2.02 1.29 1.97 1.87 1.94 1.91 1.87 1.91 0.06 
B 10 µg/ml 2.00 0.47 0.05 2.01 1.29 2.33 1.84 1.96 1.93 1.83 1.90 0.05 
C 10 µg/ml 1.98 0.48 0.07 2.00 1.32 1.94 1.87 1.94 1.91 1.89 1.89 0.05 
D 10 µg/ml 1.99 0.48 0.05 2.04 1.36 1.91 1.86 1.94 1.92 1.86 1.88 0.05 
E 10 µg/ml 2.01 0.49 0.05 2.05 1.33 1.90 1.87 1.94 2.06 1.88 1.97 0.06 
F 10 µg/ml 2.05 0.49 0.05 2.04 1.34 1.94 1.88 1.89 1.94 2.13 2.00 0.05 
G 10 µg/ml 1.99 0.47 0.05 2.02 1.31 1.93 1.82 1.90 1.88 1.88 1.95 0.06 
H 10 µg/ml 1.99 0.47 0.04 2.04 1.32 1.92 1.86 1.93 1.93 1.89 1.93 0.08 
Mean  10 µg/ml 2.0028 0.4769 0.0489 2.0270 1.3199 1.9799 1.8593 1.9299 1.9348 1.9056 1.9294 0.0575 
OD 10 µg/ml 1.9453 0.4194 -0.0086 1.9695 1.2624 1.9224 1.8018 1.8724 1.8773 1.8481 1.8719 0.0000 
 
